Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
暂无分享,去创建一个
C. Houser | S. Beriwal | J. Kelley | R. Edwards | A. Olawaiye | J. Vargo | S. Glaser | Hayeon Kim | P. Sukumvanich | J. Comerci | B. Gebhardt | M. Courtney-Brooks | R. Edwards
[1] B. Erickson,et al. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. , 2017, Brachytherapy.
[2] B. Yaremko,et al. A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. , 2016 .
[3] P. Catalano,et al. Outcomes with image-based interstitial brachytherapy for vaginal cancer. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] Christian Kirisits,et al. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Christian Kirisits,et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Christian Kirisits,et al. Descriptive Analysis of Bladder Morbidity after Definitive Radiotherapy (±Chemotherapy) and Image Guided Adaptive Brachytherapy (IGABT) for Locally Advanced Cervical Cancer. A Report from the EMBRACE Study , 2016 .
[7] Christian Kirisits,et al. Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Combined External Beam Radiotherapy, Image-Guided Adaptive Brachytherapy (IGABT) and Concomitant Chemotherapy; a Descriptive Analysis from the Embrace Study , 2016 .
[8] S. Beriwal,et al. Multichannel vaginal cylinder brachytherapy-Impact of tumor thickness and location on dose to organs at risk. , 2015, Brachytherapy.
[9] I. Hsu,et al. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes. , 2015, International journal of radiation oncology, biology, physics.
[10] S. Beriwal,et al. Brachytherapy for malignancies of the vagina in the 3D era , 2015, Journal of contemporary brachytherapy.
[11] C. Houser,et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience. , 2015, International journal of radiation oncology, biology, physics.
[12] R. Cormack,et al. A novel intracavitary applicator design for the treatment of deep vaginal fornices: preliminary dose metrics and geometric analysis , 2015, Journal of contemporary brachytherapy.
[13] Yasir A. Bahadur,et al. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning , 2014, Journal of contemporary brachytherapy.
[14] S. Beriwal,et al. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. , 2014, International journal of radiation oncology, biology, physics.
[15] M. Rajagopalan,et al. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study. , 2014, Gynecologic oncology.
[16] I. Rutten,et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. , 2014, Gynecologic oncology.
[17] E. M. Pedersen,et al. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer. , 2014, Brachytherapy.
[18] C. Houser,et al. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy. , 2014, Brachytherapy.
[19] A. Damato,et al. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer. , 2013, Gynecologic oncology.
[20] Kari Tanderup,et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective , 2013, Acta oncologica.
[21] C. Houser,et al. Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer. , 2013, Brachytherapy.
[22] C. Haie-meder,et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] J. Dimopoulos,et al. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. , 2012, International journal of radiation oncology, biology, physics.
[24] J. Dimopoulos,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] Christian Kirisits,et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] G. Matanoski,et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States , 2008, Cancer.
[27] D. Lowy,et al. Assessing the Burden of HPV-Associated Cancers in the United States HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and Women , 2008 .
[28] S. Davidson,et al. Magnetic resonance imaging of primary vaginal carcinoma. , 2007, Clinical radiology.
[29] Mitchell Morris,et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] A. Jhingran,et al. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. , 2003, International journal of radiation oncology, biology, physics.
[31] S. Nag,et al. A simple method of obtaining equivalent doses for use in HDR brachytherapy. , 2000, International journal of radiation oncology, biology, physics.
[32] T. Wong,et al. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.
[33] S. Nag,et al. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina. , 1997, Gynecologic oncology.
[34] K. Greven,et al. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer , 1994, Cancer.
[35] C. Kirisits,et al. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[37] M. Rajagopalan,et al. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States. , 2015, Practical radiation oncology.
[38] C. Houser,et al. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer. , 2015, Brachytherapy.
[39] J. Rownd,et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. , 2012, Brachytherapy.
[40] R. Stock,et al. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. , 1995, Gynecologic oncology.